Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes

[1]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[2]  S. Grundy.  Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[4]  H. Wellens,et al.  The ECG in Emergency Decision Making , 2005 .

[5]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[6]  N. Abdella,et al.  Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[7]  Anoop Misra,et al.  An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. , 2005, Diabetes care.

[8]  T. Funahashi,et al.  Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[9]  E. Tai,et al.  Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? , 2004, Diabetes care.

[10]  C. Lamendola,et al.  Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. , 2004, Metabolism: clinical and experimental.

[11]  R. Henry,et al.  Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.

[12]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[13]  A. Al-Isa.  Are Kuwaitis Getting Fatter? , 2003, Nutrition and health.

[14]  S. R. Ferreira,et al.  Two-hour insulin determination improves the ability of abdominal fat measurement to identify risk for the metabolic syndrome. , 2003, Diabetes care.

[15]  T. Funahashi,et al.  Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. , 2003, Diabetes care.

[16]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[17]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[18]  Pedro Iglesias,et al.  The role of the novel adipocyte-derived hormone adiponectin in human disease. , 2003, European journal of endocrinology.

[19]  R. Paschke,et al.  Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. , 2003, Biochemical and biophysical research communications.

[20]  H. Motoshima,et al.  Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. , 2002, The Journal of clinical endocrinology and metabolism.

[21]  A. Pfeiffer,et al.  Insulin decreases human adiponectin plasma levels. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  N. Abdella,et al.  Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. , 2002, Diabetes research and clinical practice.

[23]  W. Kraus,et al.  Adiponectin is not altered with exercise training despite enhanced insulin action. , 2002, American journal of physiology. Endocrinology and metabolism.

[24]  R. A. Norman,et al.  The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. , 2002, Diabetes.

[25]  H. Lodish,et al.  Oligomerization State-dependent Activation of NF-κB Signaling Pathway by Adipocyte Complement-related Protein of 30 kDa (Acrp30)* , 2002, The Journal of Biological Chemistry.

[26]  R. Paschke,et al.  Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. , 2002, Biochemical and biophysical research communications.

[27]  T. Funahashi,et al.  Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. , 2001, Biochemical and biophysical research communications.

[28]  R. Paschke,et al.  Adiponectin gene expression is inhibited by β‐adrenergic stimulation via protein kinase A in 3T3‐L1 adipocytes , 2001, FEBS letters.

[29]  N. Day,et al.  Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. , 2001, Diabetes care.

[30]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[31]  J. Beattie,et al.  Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ , 2001, Proceedings of the Nutrition Society.

[32]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[33]  T. McLaughlin,et al.  Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index. , 2000, Metabolism: clinical and experimental.

[34]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[35]  G. Steil,et al.  Physiological insulinemia acutely modulates plasma leptin. , 1998, Diabetes.

[36]  A. Amos,et al.  The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[37]  T Nakamura,et al.  Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. , 1994, Atherosclerosis.

[38]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[39]  Agustin Castellanos,et al.  CLINICAL CARDIAC ELECTROPHYSIOLOGY: TECHNIQUES AND INTERPRETATIONS , 1980 .

[40]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[41]  J. Goodwin,et al.  Spectrophotometry of proline in plasma and urine. , 1972, Clinical chemistry.

[42]  R. Kahn,et al.  The metabolic syndrome. , 2005, Lancet.